P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling
Abstract Background Tumor treating fields (TTFields) are an approved treatment modality for patients with glioblastoma, delivered via noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields were shown to induce abnormal mitosis, aneuploidy, and increas...
Gespeichert in:
Veröffentlicht in: | Neuro-oncology (Charlottesville, Va.) Va.), 2018-09, Vol.20 (suppl_3), p.iii281-iii282 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | iii282 |
---|---|
container_issue | suppl_3 |
container_start_page | iii281 |
container_title | Neuro-oncology (Charlottesville, Va.) |
container_volume | 20 |
creator | Porat, Y Shteingauz, A Voloshin, T Schneiderman, R Giladi, M Kirson, E Weinberg, U Kinzel, A Palti, Y |
description | Abstract
Background
Tumor treating fields (TTFields) are an approved treatment modality for patients with glioblastoma, delivered via noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields were shown to induce abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated the possible effect of TTFields on regulation of autophagy in glioma cells
Material and Methods
Cells were treated with TTFields using the inovitroTM system. Cellular granularity was evaluated using flow cytometry. Autophagy was monitored by quantifying levels of lipidated Microtubule Associated Protein Light Chain 3 (LC3-II), in the presence and absence of the lysosomotropic agent and autophagy inhibitor chloroquine (CQ), using immunoblotting and immunofluorescence microscopy. Transmission Electron Microscopy (TEM) was used to visualize autophagosome-like structures. Time-lapse microscopy was utilized to follow autophagy induction in dividing cells. Endoplasmic reticulum (ER) stress markers were monitored by immunoblotting (for GRP78) and colorimetric assay (for intracellular ATP). Evaluating the roll of AMP activated protein kinase (AMPK) in autopagy induction was conducted by immunoblotting, as well as AMPK depletion by siRNA. Involvement of autophagy in cell fate after TTFields treatment was evaluated by producing Atg7 depleted glioma cell lines via shATG7 infection, as well as by combining TTFields with CQ, and monitoring cell growth and apoptosis by flow cytometry.
Results
Significant increase in cellular granularity was demonstrated in all tested cell lines. Up-regulation of autophagy in glioma cell lines treated with TTFields was demonstrated by immunoblot analysis. Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in treated cells. Time-lapse microscopy revealed significant increase in the formation of LC3 puncta, specific to cells which divided during treatment. Indication of proteotoxic stress in treated cells was evident based on elevated GRP78 levels and decreased cellular ATP. Pathway analysis showed that AMPK activation regulates autophagy induction by TTFields. AMPK depletion from U87-MG cells resulted in autophagy inhibition as reflected by LC3-II levels. Depletion of either AMPK or Atg7 sensitized cells to the treatment, suggesting that cancer cells utilize au |
doi_str_mv | 10.1093/neuonc/noy139.249 |
format | Article |
fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6144699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noy139.249</oup_id><sourcerecordid>10.1093/neuonc/noy139.249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1779-50457117373309f91b441dc4890a70d1a20eb1fa29c09216b98cf83cb1355a703</originalsourceid><addsrcrecordid>eNqNUF1LwzAULaLgnP4A3_ID7JbbNG3zIozhVJy4h_kc0jTtIl1SmrbSf29cRfBNuHAP93xwOUFwC3gBmJGlUb01cmnsCIQtopidBTOgEQlpliTnJxyFGYX0Mrhy7gPjCGgCs8DtcLwAilZ9Z5uDqEakTdHLTluDSlvX9lObCu33G63qwiHRNLWW4kQ71Q7Kn_wg17eDHkSNjkoehNHu6FGhRacKlI9o9bp7QU5XRtQ-7jq4KEXt1M3Pngfvm4f9-incvj0-r1fbUEKaspDimKYAKUkJwaxkkMcxFDLOGBYpLkBEWOVQiohJzCJIcpbJMiMyB0KpV5B5cD_lNn3uv5HKdK2oedPqo2hHboXmfxmjD7yyA08gjhPGfABMAbK1zrWq_PUC5t-186l2PtXOfe3eczd5bN_8Q_4Fl4KJXA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Porat, Y ; Shteingauz, A ; Voloshin, T ; Schneiderman, R ; Giladi, M ; Kirson, E ; Weinberg, U ; Kinzel, A ; Palti, Y</creator><creatorcontrib>Porat, Y ; Shteingauz, A ; Voloshin, T ; Schneiderman, R ; Giladi, M ; Kirson, E ; Weinberg, U ; Kinzel, A ; Palti, Y</creatorcontrib><description>Abstract
Background
Tumor treating fields (TTFields) are an approved treatment modality for patients with glioblastoma, delivered via noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields were shown to induce abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated the possible effect of TTFields on regulation of autophagy in glioma cells
Material and Methods
Cells were treated with TTFields using the inovitroTM system. Cellular granularity was evaluated using flow cytometry. Autophagy was monitored by quantifying levels of lipidated Microtubule Associated Protein Light Chain 3 (LC3-II), in the presence and absence of the lysosomotropic agent and autophagy inhibitor chloroquine (CQ), using immunoblotting and immunofluorescence microscopy. Transmission Electron Microscopy (TEM) was used to visualize autophagosome-like structures. Time-lapse microscopy was utilized to follow autophagy induction in dividing cells. Endoplasmic reticulum (ER) stress markers were monitored by immunoblotting (for GRP78) and colorimetric assay (for intracellular ATP). Evaluating the roll of AMP activated protein kinase (AMPK) in autopagy induction was conducted by immunoblotting, as well as AMPK depletion by siRNA. Involvement of autophagy in cell fate after TTFields treatment was evaluated by producing Atg7 depleted glioma cell lines via shATG7 infection, as well as by combining TTFields with CQ, and monitoring cell growth and apoptosis by flow cytometry.
Results
Significant increase in cellular granularity was demonstrated in all tested cell lines. Up-regulation of autophagy in glioma cell lines treated with TTFields was demonstrated by immunoblot analysis. Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in treated cells. Time-lapse microscopy revealed significant increase in the formation of LC3 puncta, specific to cells which divided during treatment. Indication of proteotoxic stress in treated cells was evident based on elevated GRP78 levels and decreased cellular ATP. Pathway analysis showed that AMPK activation regulates autophagy induction by TTFields. AMPK depletion from U87-MG cells resulted in autophagy inhibition as reflected by LC3-II levels. Depletion of either AMPK or Atg7 sensitized cells to the treatment, suggesting that cancer cells utilize autophagy as a resistance mechanism to TTFields. Combining TTFields with CQ resulted in a significant dose-dependent reduction of cell growth compared with TTFields or CQ alone.
Conclusion
These results suggest that dividing cells upregulate autophagy in response to aneuploidy and ER stress induced by TTFields application and that AMPK may serve as a key regulator of this process.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noy139.249</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Poster Presentations</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii281-iii282</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144699/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144699/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1584,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Porat, Y</creatorcontrib><creatorcontrib>Shteingauz, A</creatorcontrib><creatorcontrib>Voloshin, T</creatorcontrib><creatorcontrib>Schneiderman, R</creatorcontrib><creatorcontrib>Giladi, M</creatorcontrib><creatorcontrib>Kirson, E</creatorcontrib><creatorcontrib>Weinberg, U</creatorcontrib><creatorcontrib>Kinzel, A</creatorcontrib><creatorcontrib>Palti, Y</creatorcontrib><title>P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>Abstract
Background
Tumor treating fields (TTFields) are an approved treatment modality for patients with glioblastoma, delivered via noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields were shown to induce abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated the possible effect of TTFields on regulation of autophagy in glioma cells
Material and Methods
Cells were treated with TTFields using the inovitroTM system. Cellular granularity was evaluated using flow cytometry. Autophagy was monitored by quantifying levels of lipidated Microtubule Associated Protein Light Chain 3 (LC3-II), in the presence and absence of the lysosomotropic agent and autophagy inhibitor chloroquine (CQ), using immunoblotting and immunofluorescence microscopy. Transmission Electron Microscopy (TEM) was used to visualize autophagosome-like structures. Time-lapse microscopy was utilized to follow autophagy induction in dividing cells. Endoplasmic reticulum (ER) stress markers were monitored by immunoblotting (for GRP78) and colorimetric assay (for intracellular ATP). Evaluating the roll of AMP activated protein kinase (AMPK) in autopagy induction was conducted by immunoblotting, as well as AMPK depletion by siRNA. Involvement of autophagy in cell fate after TTFields treatment was evaluated by producing Atg7 depleted glioma cell lines via shATG7 infection, as well as by combining TTFields with CQ, and monitoring cell growth and apoptosis by flow cytometry.
Results
Significant increase in cellular granularity was demonstrated in all tested cell lines. Up-regulation of autophagy in glioma cell lines treated with TTFields was demonstrated by immunoblot analysis. Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in treated cells. Time-lapse microscopy revealed significant increase in the formation of LC3 puncta, specific to cells which divided during treatment. Indication of proteotoxic stress in treated cells was evident based on elevated GRP78 levels and decreased cellular ATP. Pathway analysis showed that AMPK activation regulates autophagy induction by TTFields. AMPK depletion from U87-MG cells resulted in autophagy inhibition as reflected by LC3-II levels. Depletion of either AMPK or Atg7 sensitized cells to the treatment, suggesting that cancer cells utilize autophagy as a resistance mechanism to TTFields. Combining TTFields with CQ resulted in a significant dose-dependent reduction of cell growth compared with TTFields or CQ alone.
Conclusion
These results suggest that dividing cells upregulate autophagy in response to aneuploidy and ER stress induced by TTFields application and that AMPK may serve as a key regulator of this process.</description><subject>Poster Presentations</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNUF1LwzAULaLgnP4A3_ID7JbbNG3zIozhVJy4h_kc0jTtIl1SmrbSf29cRfBNuHAP93xwOUFwC3gBmJGlUb01cmnsCIQtopidBTOgEQlpliTnJxyFGYX0Mrhy7gPjCGgCs8DtcLwAilZ9Z5uDqEakTdHLTluDSlvX9lObCu33G63qwiHRNLWW4kQ71Q7Kn_wg17eDHkSNjkoehNHu6FGhRacKlI9o9bp7QU5XRtQ-7jq4KEXt1M3Pngfvm4f9-incvj0-r1fbUEKaspDimKYAKUkJwaxkkMcxFDLOGBYpLkBEWOVQiohJzCJIcpbJMiMyB0KpV5B5cD_lNn3uv5HKdK2oedPqo2hHboXmfxmjD7yyA08gjhPGfABMAbK1zrWq_PUC5t-186l2PtXOfe3eczd5bN_8Q_4Fl4KJXA</recordid><startdate>20180919</startdate><enddate>20180919</enddate><creator>Porat, Y</creator><creator>Shteingauz, A</creator><creator>Voloshin, T</creator><creator>Schneiderman, R</creator><creator>Giladi, M</creator><creator>Kirson, E</creator><creator>Weinberg, U</creator><creator>Kinzel, A</creator><creator>Palti, Y</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180919</creationdate><title>P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling</title><author>Porat, Y ; Shteingauz, A ; Voloshin, T ; Schneiderman, R ; Giladi, M ; Kirson, E ; Weinberg, U ; Kinzel, A ; Palti, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1779-50457117373309f91b441dc4890a70d1a20eb1fa29c09216b98cf83cb1355a703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Poster Presentations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Porat, Y</creatorcontrib><creatorcontrib>Shteingauz, A</creatorcontrib><creatorcontrib>Voloshin, T</creatorcontrib><creatorcontrib>Schneiderman, R</creatorcontrib><creatorcontrib>Giladi, M</creatorcontrib><creatorcontrib>Kirson, E</creatorcontrib><creatorcontrib>Weinberg, U</creatorcontrib><creatorcontrib>Kinzel, A</creatorcontrib><creatorcontrib>Palti, Y</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Porat, Y</au><au>Shteingauz, A</au><au>Voloshin, T</au><au>Schneiderman, R</au><au>Giladi, M</au><au>Kirson, E</au><au>Weinberg, U</au><au>Kinzel, A</au><au>Palti, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2018-09-19</date><risdate>2018</risdate><volume>20</volume><issue>suppl_3</issue><spage>iii281</spage><epage>iii282</epage><pages>iii281-iii282</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Abstract
Background
Tumor treating fields (TTFields) are an approved treatment modality for patients with glioblastoma, delivered via noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields were shown to induce abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated the possible effect of TTFields on regulation of autophagy in glioma cells
Material and Methods
Cells were treated with TTFields using the inovitroTM system. Cellular granularity was evaluated using flow cytometry. Autophagy was monitored by quantifying levels of lipidated Microtubule Associated Protein Light Chain 3 (LC3-II), in the presence and absence of the lysosomotropic agent and autophagy inhibitor chloroquine (CQ), using immunoblotting and immunofluorescence microscopy. Transmission Electron Microscopy (TEM) was used to visualize autophagosome-like structures. Time-lapse microscopy was utilized to follow autophagy induction in dividing cells. Endoplasmic reticulum (ER) stress markers were monitored by immunoblotting (for GRP78) and colorimetric assay (for intracellular ATP). Evaluating the roll of AMP activated protein kinase (AMPK) in autopagy induction was conducted by immunoblotting, as well as AMPK depletion by siRNA. Involvement of autophagy in cell fate after TTFields treatment was evaluated by producing Atg7 depleted glioma cell lines via shATG7 infection, as well as by combining TTFields with CQ, and monitoring cell growth and apoptosis by flow cytometry.
Results
Significant increase in cellular granularity was demonstrated in all tested cell lines. Up-regulation of autophagy in glioma cell lines treated with TTFields was demonstrated by immunoblot analysis. Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in treated cells. Time-lapse microscopy revealed significant increase in the formation of LC3 puncta, specific to cells which divided during treatment. Indication of proteotoxic stress in treated cells was evident based on elevated GRP78 levels and decreased cellular ATP. Pathway analysis showed that AMPK activation regulates autophagy induction by TTFields. AMPK depletion from U87-MG cells resulted in autophagy inhibition as reflected by LC3-II levels. Depletion of either AMPK or Atg7 sensitized cells to the treatment, suggesting that cancer cells utilize autophagy as a resistance mechanism to TTFields. Combining TTFields with CQ resulted in a significant dose-dependent reduction of cell growth compared with TTFields or CQ alone.
Conclusion
These results suggest that dividing cells upregulate autophagy in response to aneuploidy and ER stress induced by TTFields application and that AMPK may serve as a key regulator of this process.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/noy139.249</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1522-8517 |
ispartof | Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii281-iii282 |
issn | 1522-8517 1523-5866 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6144699 |
source | Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Poster Presentations |
title | P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T08%3A39%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P04.15%20Autophagy%20induction%20following%20TTFields%20application%20serves%20as%20a%20survival%20mechanism%20mediated%20by%20AMPK%20signaling&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Porat,%20Y&rft.date=2018-09-19&rft.volume=20&rft.issue=suppl_3&rft.spage=iii281&rft.epage=iii282&rft.pages=iii281-iii282&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noy139.249&rft_dat=%3Coup_pubme%3E10.1093/neuonc/noy139.249%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/neuonc/noy139.249&rfr_iscdi=true |